300404 Boji Medical Technology
- 7.90
- -0.29-3.54%
Boji Medical Technology News
Boji Pharmaceutical: Announcement on the use of temporarily idle funds raised for cash management and maturity redemption
Boji Pharmaceutical: Announcement on the Company\'s Obtaining a Notice of Approval for Drug Clinical Trials
Boji Pharmaceutical: Report of GF Securities Co., Ltd. on the company\'s 2024 continuous supervision and training work
Boji Pharmaceutical: Guangfa Securities Co., Ltd.\'s 2024 Continuous Supervision Site Inspection Report
Boji Pharmaceutical: Announcement on the Company Obtaining an Invention Patent Certificate
Boji Pharmaceutical: Announcement of Resolutions of the 12th Meeting of the Fifth Board of Directors
Boji Pharmaceuticals: Announcement on Cancelling the Company\'s Voluntary Disclosure Standards
Boji Pharmaceutical: Announcement on the Company Obtaining an Invention Patent Certificate
Boji Pharmaceutical: Progress Announcement on the Use of Temporarily Idle Raised Funds for Cash Management and Expiry and Redemption
Boji Pharmaceuticals: Announcement on the completion of the cancellation of some restricted stock repurchases
Boji Pharmaceutical: Announcement on the Wholly-owned Subsidiary Obtaining an Invention Patent Certificate
Boji Pharmaceutical: Announcement on the company being recognized as a national specialized, special and new “little giant” enterprise
Boji Pharmaceutical: Announcement on the expiration and completion of the controlling shareholders\' unanimous action plan to reduce their holdings
Broge Pharmaceuticals: Announcement on the completion of cancellation of some stock options
Boji Pharmaceutical: Announcement on the cancellation of the pledge of part of the controlling shareholder\'s shares
Boji Pharmaceuticals: 300404 Boji Pharmaceuticals Investor Relations Management Information 20241028
Boji Pharmaceutical: Beijing Kangda (Guangzhou) Law Firm\'s Legal Opinion on the Company\'s Cancellation of Some Restricted Shares
Boji Pharmaceutical: Beijing Kangda (Guangzhou) Law Firm\'s Legal Opinion on the Company\'s Cancellation of Some Stock Options
Broge Pharmaceuticals: Announcement on the abolition of some restricted stocks
Boji Pharmaceuticals: Announcement on Accruing Asset Impairment Losses, Credit Impairment Losses, and Asset Write-off
No Data
